SOLGAR VITAMIN AND HERB COMPANY, INC. – Trademark Portfolio

Entity Type: 03

SOLGAR VITAMIN AND HERB COMPANY, INC. holds 34 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 34 filings in this category. Currently, 11 trademarks are registered. Notable registered marks include VM-75, HY-BIO, OMNIUM, SOLGAR, and PHYTO2X. The owner is based in Bohemia, NY.

90 Orville Drive

Legal Department

Bohemia, NY 11716

34 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Page 1 of 2 (34 results)

Trademark Classifications

SOLGAR VITAMIN AND HERB COMPANY, INC.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (34 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does SOLGAR VITAMIN AND HERB COMPANY, INC. have?

SOLGAR VITAMIN AND HERB COMPANY, INC. has 34 U.S. trademarks filed with the USPTO. Of these, 11 registered, 15 abandoned, 8 cancelled.

What trademark classes does SOLGAR VITAMIN AND HERB COMPANY, INC. file in?

SOLGAR VITAMIN AND HERB COMPANY, INC. files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are SOLGAR VITAMIN AND HERB COMPANY, INC.'s most well-known trademarks?

SOLGAR VITAMIN AND HERB COMPANY, INC.'s registered trademark portfolio includes well-known marks such as VM-75, HY-BIO, OMNIUM, SOLGAR, and PHYTO2X. These are among 11 currently registered trademarks in the portfolio.

What is SOLGAR VITAMIN AND HERB COMPANY, INC.'s trademark registration success rate?

SOLGAR VITAMIN AND HERB COMPANY, INC. has a 32% trademark registration rate, with 11 out of 34 resolved applications resulting in successful registration. Currently, 0 applications are pending review.